ICAN's Nobel Peace Prize Is Humanity's Rx for Survival

"The prize is a tribute to the survivors of the atomic bombings of Hiroshima and Nagasaki, the hibakusha, and victims of nuclear explosions and development around the world and their vision to prevent future generations from suffering the horror of nuclear detonation," Dodge writes. (Photo: ICAN)

ICAN's Nobel Peace Prize Is Humanity's Rx for Survival

Nuclear weapons are the greatest threat to our humanity and the U.N. Treaty, through the work of ICAN, is now our prescription for survival.

Friday's award of the Nobel Peace Prize for 2017 to the International Campaign to Abolish Nuclear Weapons (ICAN) draws attention to the catastrophic humanitarian consequences of any use of nuclear weapons and the global movement to abolish these weapons as the only reliable way to guarantee that they will never be used again. The award brings the reality of these consequences front and center to the world stage. The nuclear armed states with their addiction to nuclear weapons due to their misguided false sense of security in having these weapons and their refusal to proceed further with the disarmament process will now be legally bound to abide by the Nuclear Non-Proliferation Treaty. This award stigmatizes the nuclear armed states with their nuclear stockpiles and empowers the non-nuclear nations who have spoken out in the adoption of this summer's Treaty on the Prohibition of Nuclear Weapons.

Physicians for Social Responsibility's international federation, the International Physicians for the Prevention of Nuclear War, itself a recipient of the 1985 Nobel peace prize, founded ICAN in 2007. PSR worked with ICAN presenting scientific data on the humanitarian and medical consequences of nuclear weapons at a series of three intergovernmental conferences in 2013 and 2014, the 2016 UN multilateral disarmament forum which ultimately led to the 2017 UN treaty negotiations and adoption of the landmark Treaty on the Prohibition of Nuclear Weapons by 122 nations on July 7, 2017. The Treaty prohibits the use, threat of use, development, testing, acquisition, stockpiling and transfer of these weapons and forever stigmatizes these weapons and the nations who maintain their nuclear stockpiles.

The small and mighty permanent staffing of ICAN has allowed it to be nimble and strategic in its work, engaging a diverse range of groups and working alongside the Red Cross and like-minded governments. It has built a mighty global coalition of over 400 partners in 101 nations creating a movement that is unstoppable and along the way has reshaped the debate on nuclear weapons generating a momentum towards elimination.

ICAN typifies the often quoted words of Margaret Mead, "Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has."

The prize is a tribute to the survivors of the atomic bombings of Hiroshima and Nagasaki, the hibakusha, and victims of nuclear explosions and development around the world and their vision to prevent future generations from suffering the horror of nuclear detonation.

Until now, nuclear weapons were the only indiscriminate weapon of war that had not been banned. Chemical and biological weapons, as well as landmines and cluster munitions, have already been banned. Nuclear weapons are the greatest threat to our humanity and the U.N. Treaty, through the work of ICAN, is now our prescription for survival.

Join Us: News for people demanding a better world


Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place.

We're hundreds of thousands strong, but every single supporter makes the difference.

Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. Join with us today!

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.